JC: AVP in Haemorrhagic Shock. St Emlyn’s
Could arginine vasopressin reduce blood-product requirements after major traumatic haemorrhage? This appraisal reviews a small single-centre randomised trial, examining reduced transfusion use alongside the lack of a demonstrated mortality benefit and the limits of applying its findings to a broader trauma population.
JC: AVP in Haemorrhagic Shock. St Emlyn’s Read More


